Dr Miloš Petrović

internal medicine

Dr Miloš Petrović

Education:

  • 1998 Medical Doctor, School of Medicine, University of Belgrade, Serbia (GPA: 9,94 out of 10,00)
  • 1999 Medical Licence, Republic of Serbia (maintaining full licence ever since)
  • 2005 Neuroscience PhD thesis, 1st School of Medicine, Charles University, Prague, Czech
    Republic
  • 2007 Clinical specialization in internal medicine, School of Medicine, University of Belgrade,
    Serbia

Work Experience:

  • 1999-2012 Teaching Assistant, Medical School, University of Belgrade
  • 2009 – 2011 Neuroscience Marie Curie Research Fellow, Medical Research Council Centre for Synaptic Plasticity, Bristol University, UK
  • 2012 – 2014 Assistant Professor, Medical School, University of Belgrade
  • 2012 – 2014 Neuroscience Marie Curie Career Integration Grant Fellow, Centro de Investigación Médica Aplicada, University of Navarra, Pamplona, Spain
  • 2014 – 2017 Reader in Neuroscience, School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, UK
  • 2017 – 2019 Medical Advisor, Immunology/Dermatology, Sanofi, Reading, UK
  • 2019 – 2020 Global Safety Officer (Pharmacovigilance), Oncology, Sanofi, Reading, UK
  • 2020 – 2022 Director of Clinical Research, Neuroscience rare diseases, Sanofi, Reading, UK
  • 2022 – 2023 Medical lead UK & Ireland, Rare Diseases, CSL Vifor, UK& Ireland
  • 2023 – Head of Emergency medicine department, Clinical Hospital Centre Dragisa Misovic, Belgrade, Serbia

Publications:

1.  Gajic I, Kekic D, Jankovic M, Tomic N, Skoric M, Petrovic M, Mitic Culafic D, Opavski N, Ristivojevic P, Krstic Ristivojevic M, Lukovic B. Nature’s Arsenal: Uncovering Antibacterial Agents Against Antimicrobial Resistance. Antibiotics, 2025. (accepted for publication), https://doi.org/10.3390/antibiotics14030253
2. Gajic I, Tomic N, Lukovic B, Jovicevic M, Kekic D, Petrovic M, Jankovic M, Trudic A, Mitic Culafic D, Milenkovic M, Opavski N. A comprehensive overview on antibacterial agents for combating multidrug-resistant bacteria: the current landscape, development, future opportunities, and challenges. Antibiotics, 2025 (accepted for publication), https://doi.org/10.3390/antibiotics14030221
3. McPherson T., Cork M.J., Goodhead C., Michaelis L.J., Flohr C., Petrovic M., Hennessy L., Rajkovic I., Hudson R. A real-world retrospective observational study exploring NHS resource use in England for the management of moderate-to-severe atopic dermatitis in secondary care for children and adolescents. Pediatric Dermatology. 2023;40(1):50-63.
4. Hudson R.D.A., Ameen M., George S.M.C., Harwood C.A., Weller R.B., Lear J.T., Rout R., Surendranathan T., Petrovic M., Bewley A.P. A Real-World Data Study on the Healthcare Resource Use for Uncontrolled Moderate-to Severe Atopic Dermatitis in Secondary Care in the United Kingdom Prior to the Introduction of Biologic Treatment. Clinico Economics and Outcomes Research. 2022;14:167-177.
5. Petrovic MM*, Viana da Silva S, Clement JP, Vyklicky L, Mulle C, González-González IM*, Henley JM*. Metabotropic action of postsynaptic kainate receptors triggers hippocampal long-term potentiation, Nature Neuroscience, 2017 Apr;20(4):529-539. *co-corresponding authors
6. Marco S*, Giralt A*, Petrovic MMǂ, Pouladi MA, Martínez-Turrillas R, Martínez-Hernández J, Kaltenbach LS, Torres-Peraza J, Graham RK, Watanabe M, Luján R, Nakanishi N, Lipton SA, Lo DC, Hayden MR, Alberch J, Wesseling JF, Pérez-Otaño I. (2013). Reversing aberrant GluN3A expression rescues synapse loss and motor and cognitive dysfunction in HD mouse models, Nature Medicine, 2013 Jul 14. doi: 10.1038/nm.3246., *equal contribution, ǂ second author
7. Buchanan KA*, Petrovic MM*, Chamberlain SEL, Marrion NV, Mellor JR. (2010). Facilitation of Long-Term Potentiation by Muscarinic M1 Receptors in the Hippocampus is mediated by inhibition of SK channels. Neuron 68(5):948-963, *equal contribution
8. Petrovic M, Sedlacek M, Horak M, Chodounska H, Ladislav Vyklicky Jr. (2005). 20-oxo-5β-pregnan-3α-ylsulfate is a use-dependent NMDA receptor inhibitor. Journal of Neuroscience. 25(37):8439–8450. This paper was awarded by Czech Neuroscience Society.
9. Lukic J, Ilic S, Zivic R, Mitic S, Savic P, Vukomanovic V and Petrovic M.  Case Report: Adrenal collision tumor composed of oncocytoma pheochromocytoma. Frontiers in Oncology. 15:1554355. doi: 10.3389/fonc.2025.1554355. Accepted for publication.  IF=3.3

Internists